click below
click below
Normal Size Small Size show me how
Pharm Chapter 35
Term | Definition |
---|---|
Diabetes mellitus | A group of diseases characterized by hyperglycemia (fasting plasma glucose level >100 mg/dL) and abnormalities in fat, carbohydrate, and protein metabolism that lead to microvascular, macrovascular, and neuropathic complications. |
Hyperglycemia | Fasting plasma glucose level of >100mg/dL. |
Type 1 diabetes mellitus | Insulin dependent. |
Type 2 diabetes mellitus | Non insulin dependent. |
Gestational diabetes mellitus | Women who show abnormal glucose tolerance during pregnancy. |
Impaired glucose tolerance | Blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis |
Impaired fasting glucose | When blood glucose levels in the body are raised, but are not high enough to mean that the person has diabetes |
Prediabetes | The intermediate stage between normal glucose homeostasis and diabetes. |
Microvascular complications | Those that arise from destruction of capillaries in the eyes, kidneys, and peripheral nerve damage. |
Macrovascular complications | Those associated with atherosclerosis of middle to large arteries, such as those in the heart and brain. |
Neuropathies | May first be observed as numbness or tingling of the extremities (paresthesia), loss of sensation, orthostatic hypotension, impotence, vaginal yeast (candidiasis) infections, and difficulty in controlling urination (neurogenic bladder). |
Paresthesia | Numbess or tingling of the extremities. |
Medical nutrition therapy (MNT) | Nutrition-based treatment provided by a registered dietitian nutritionist.” It includes “a nutrition diagnosis as well as therapeutic and counseling services to help manage diabetes.” |
Hypoglycemia | Blood glucose level less than 70 mg/dL. |
Intensive therapy | Describes a comprehensive program of diabetes care that includes patient-centered communication, a team approach to care, self-monitoring of blood glucose four or more times daily. |